These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 15287238)
1. Effect on amphotericin B lipid complex use of a clinical decision support system for computerized prescriber order entry. Collins CD; Pedersen CA; Schneider PJ; Miller AS; Sierawski SJ; Roux RK Am J Health Syst Pharm; 2004 Jul; 61(13):1395-9. PubMed ID: 15287238 [No Abstract] [Full Text] [Related]
2. Estimating the true cost of amphotericin B. Rex JH; Walsh TJ Clin Infect Dis; 1999 Dec; 29(6):1408-10. PubMed ID: 10585787 [No Abstract] [Full Text] [Related]
3. What is the current and future status of conventional amphotericin B? Kleinberg M Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():12-6. PubMed ID: 16707251 [TBL] [Abstract][Full Text] [Related]
4. Efficacy, safety and cost-effectiveness of Amphotericin B Lipid Complex (ABLC): a review of the literature. Martino R Curr Med Res Opin; 2004 Apr; 20(4):485-504. PubMed ID: 15119986 [TBL] [Abstract][Full Text] [Related]
5. Lipid amphotericin B combinations; 'la crème de la crème'? Hay RJ J Infect; 1999 Jul; 39(1):16-20. PubMed ID: 10468123 [No Abstract] [Full Text] [Related]
7. Controlled trials of amphotericin B lipid complex and other lipid-associated formulations. Winston DJ; Schiller GJ Clin Infect Dis; 2000 Jan; 30(1):236-7. PubMed ID: 10619780 [No Abstract] [Full Text] [Related]
8. Communication averts an overdose. Lilley LL; Guanci R Am J Nurs; 1998 Mar; 98(3):12. PubMed ID: 9536168 [No Abstract] [Full Text] [Related]
9. Criteria for use of amphotericin B lipid complex injections in adults and children. Am J Health Syst Pharm; 1996 Nov; 53(22):2751-2. PubMed ID: 9072180 [No Abstract] [Full Text] [Related]
10. Amphotericin B lipid complex therapy in an AIDS patient with Rhodotorula rubra fungemia. Lui AY; Turett GS; Karter DL; Bellman PC; Kislak JW Clin Infect Dis; 1998 Oct; 27(4):892-3. PubMed ID: 9798050 [No Abstract] [Full Text] [Related]
12. Worsening of endogenous Candida albicans endophthalmitis during therapy with intravenous lipid complex amphotericin B. Virata SR; Kylstra JA; Brown JC; Wohl DA; Cohen MS Clin Infect Dis; 1999 May; 28(5):1177-8. PubMed ID: 10452666 [No Abstract] [Full Text] [Related]
13. Amphotericin B lipid complex for the treatment of recurrent blastomycosis of the brain in a patient previously treated with itraconazole. Cook PP South Med J; 2001 May; 94(5):548-9. PubMed ID: 11372815 [TBL] [Abstract][Full Text] [Related]
14. Successful treatment of disseminated coccidioidomycosis with amphotericin B lipid complex. Koehler AP; Cheng AF; Chu KC; Chan CH; Ho AS; Lyon DJ J Infect; 1998 Jan; 36(1):113-5. PubMed ID: 9515680 [TBL] [Abstract][Full Text] [Related]
18. Mortality rates in comparative trials of formulations of amphotericin B. Frothingham R Clin Infect Dis; 2001 Aug; 33(4):582-3. PubMed ID: 11462201 [No Abstract] [Full Text] [Related]
19. Disseminated fungemia due to Candida krusei with cutaneous lesions and successful treatment by amphotericin B lipid complex and catheter removal: a case report. Hourez R; Gillard PH; Mariat P; Aoun M Int J Infect Dis; 2002 Dec; 6(4):326-8. PubMed ID: 12725216 [No Abstract] [Full Text] [Related]
20. Amphotericin B lipid complex in the treatment of invasive fungal infections: results of the Collaborative Exchange of Antifungal Research (CLEAR), an industry-supported patient registry. Pappas PG Clin Infect Dis; 2005 May; 40 Suppl 6():S379-83. PubMed ID: 15809923 [No Abstract] [Full Text] [Related] [Next] [New Search]